More importantly, we demonstrated that the knockdown of IGFBP3 efficiently suppressed APOE ε4-dependent AD pathologies during amyloid early-seeding stage in sporadic AD patient iNs, suggesting the role of IGFBP3 in APOE ε4-induced AD phenotypes. This evidence concerns the gene IGFBP3 and Alzheimer disease.